Study dismisses PPI cancer link

Long-term use of proton pump inhibitors (PPIs) does not appear to increase the risk of developing oesophageal cancer, UK research has found.

It has been suggested that long-term PPI use to reduce the discomfort of heartburn could increase the risk of developing Barrett's Oesophagus (BE), which can in turn develop into oesophageal adenocarcinoma.

Researchers from Leicester Royal Infirmary and Queen Mary, University of London looked at tissue samples from the oesophagus lining of 90 volunteers, each of whom were given high or low PPI dosages.

Overall, there was no difference in the rate of BE development nor change in levels of pre-cancerous cells in either group.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus